MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2013.06.018

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2013

Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.

Dubois Ludwig, Peeters Sarah G J A, van Kuijk Simon J A, Yaromina Ala, Lieuwes Natasja G, Saraya Ruchi, Biemans Rianne, Rami Marouan, Parvathaneni Nanda Kumar, Vullo Daniela, Vooijs Marc, Supuran Claudiu T, Winum Jean-Yves, Lambin Philippe

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND PURPOSE: Carbonic anhydrase IX (CAIX) plays an important role in pH regulation processes critical for tumor cell growth and metastasis. We hypothesize that a dual targeting bioreductive nitroimidazole based anti-CAIX sulfamide drug (DH348) will reduce tumor growth and sensitize tumors to irradiation in a CAIX dependent manner.

MATERIAL AND

METHODS

The effect of the dual targeting anti-CAIX (DH348) and its single targeting control drugs on extracellular acidification and radiosensitivity was examined in HT-29 colorectal carcinoma cells. Tumor growth and time to reach 4× start volume (T4×SV) was monitored for animals receiving DH348 (10 mg/kg) combined with tumor single dose irradiation (10 Gy).

RESULTS

In vitro, DH348 reduced hypoxia-induced extracellular acidosis, but did not change hypoxic radiosensitivity. In vivo, DH348 monotherapy decreased tumor growth rate and sensitized tumors to radiation (enhancement ratio 1.50) without systemic toxicity only for CAIX expressing tumors.

CONCLUSIONS

A newly designed nitroimidazole and sulfamide dual targeting drug reduces hypoxic extracellular acidification, slows down tumor growth at nontoxic doses and sensitizes tumors to irradiation all in a CAIX dependent manner, suggesting no "off-target" effects. Our data therefore indicate the potential utility of a dual drug approach as a new strategy for tumor-specific targeting.

Для цитирования: Dubois Ludwig, Peeters Sarah G J A, van Kuijk Simon J A, Yaromina Ala, Lieuwes Natasja G, Saraya Ruchi, Biemans Rianne, Rami Marouan, Parvathaneni Nanda Kumar, Vullo Daniela, Vooijs Marc, Supuran Claudiu T, Winum Jean-Yves, Lambin Philippe. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2013. DOI: 10.1016/j.radonc.2013.06.018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.